Impacto de la medicina regenerativa en angiología. Experiencia cubana

Hernández Ramírez, Porfirio; Artaza Sánz, Heriberto; Aparicio Suárez, José Luis; Cruz Tamayo, Fernando; Díaz Díaz, Antonio Jesús; Fernández Delgado, Norma; Fernández Águila, Julio; Gámez Pérez, Anadely; González Iglesias, Ana Iris; León Amado, Lisset.
Rev. cuba. angiol. cir. vasc ; 18(1): 3-18, ene.-jun. 2017. ilus
Artigo em Espanhol | LILACS, CUMED | ID: biblio-844802

Documentos relacionados

  1. Function-first ligandomics for ocular vascular research and drug target discovery.
  2. Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine.
  3. The Intervention of Nano-targeted Drugs & Angioplastryin Treatment and Prevention of Vascular Restenosis and its Influence on Monocyte Chemotactic Protein-1 in Lower Extremity Angiopathy.
  4. Carnosine as a potential therapeutic for the management of peripheral vascular disease.
  5. How to establish infrastructures to achieve more efficient regenerative medicine?
  6. [Best medical treatment of lower extremity arterial disease in 2018].
  7. Advances and potential of regenerative medicine in pediatric nephrology.
  8. Current status and prospects of organoid-based regenerative medicine.
  9. Successful Catheter-Directed Thrombolysis for Acute Lower Limb Ischemia Secondary to COVID-19 Infection.
  10. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.